Taiwan's COVID-19 vaccine could begin human trials this fall: VP

A vaccine Taiwan's National Health Research Institutes (NHRI) is developing for the novel coronavirus disease (COVID-19) will enter human trials as early as this autumn, Vice President Lai Ching-te (賴清德) disclosed Friday.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)